Leukotriene Receptor Antagonist and Antihistamines for Asthma Treatments

Leukotriene Receptor Antagonist
Antihistamines have been shown to be effective in seasonal allergic rhinitis and chronic idiopathic urticaria. They improve quality of life scores, acute inflammatory response markers in atopic dermatitis asthma and symptom scores. Newer histamine H1-receptor antagonists may also have an antiplatelet-activating factor effect and are equally effective in seasonal allergic rhinitis. The antileukotrienes were developed in the 1980s. The first compounds of this novel class of anti-asthma drugs were registered in the second half of the 1990s. The mechanism of action of the cysteinyl leukotriene receptor antagonists (LTRAs) is based on counteracting the effects of cysteinyl leukotrienes at their receptor site (CysLT1 receptor) within the airways. (more…)

Acute Inflammatory Response — Know About Acute Inflammation Reaction

acute inflammatory response
Acute inflammatory response constitute the first line of defense against infection pathogenesis and how immune system works as well as the initial stage in restoring injured tissue to normalcy. Acute inflammation is recognized by redness, swelling, heat and pain in the affected area. These symptoms stem from a multitude of events taking place within the inflamed site. The humoral arm of the immune response, including circulating antibodies and the complement system, is activated. (more…)